DR. YAMUNA KASARANENI M.D.
Prescription History 1528097607
Family Medicine in Greenwood, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. YAMUNA KASARANENI M.D., an active Family Medicine specialist practicing in Greenwood, IN. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 408 documented patient claims. Among these therapy options, the most frequently utilized medication is Cephalexin, which accounts for 167 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Cephalexin | 167 | $6.26▼ below IN avg | ▲ More than typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2023, this provider wrote 167 Medicare prescriptions for Cephalexin, about 5.1 times the volume of the typical Indiana prescriber of this medication (33). Medicare paid an average of $6.26 per fill, versus $8.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 167 30-Day Fills standardized to 30-day supplies 1,081 Days of Medication total across all patients in 2023 | |||
| Methylprednisolone | 46 | $7.91▼ below IN avg | ▲ More than typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2023, this provider wrote 46 Medicare prescriptions for Methylprednisolone, about 1.4 times the volume of the typical Indiana prescriber of this medication (34). Medicare paid an average of $7.91 per fill, versus $9.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 46 30-Day Fills standardized to 30-day supplies 274 Days of Medication total across all patients in 2023 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $10.77▼ below IN avg | ▲ More than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate. In 2023, this provider wrote 35 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 1.4 times the volume of the typical Indiana prescriber of this medication (25). Medicare paid an average of $10.77 per fill, versus $12.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 35 30-Day Fills standardized to 30-day supplies 235 Days of Medication total across all patients in 2023 | |||
| Doxycycline Monohydrate | 23 | $13.38▼ below IN avg | ≈ Typical |
About Doxycycline Monohydrate: This medication is used to treat a certain type of skin condition called rosacea. Show more ▾ It helps to reduce the number of pimples and bumps on the face, but it may not decrease redness. It works by reducing skin inflammation caused by rosacea. Although doxycycline belongs to the class of antibiotics known as tetracyclines, this product does not work as an antibiotic because it does not stop the growth of bacteria. Do not use this product to treat any infection, including viral infections (such as the common cold, flu). Use this medication only as prescribed by your doctor. A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE. In 2023, this provider wrote 23 Medicare prescriptions for Doxycycline Monohydrate, about 82% of the volume of the typical Indiana prescriber of this medication (28). Medicare paid an average of $13.38 per fill, versus $23.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 23 30-Day Fills standardized to 30-day supplies 168 Days of Medication total across all patients in 2023 | |||
| Lagevrio (Eua)Molnupiravir | 23 | $10.67▼ below IN avg | ▲ More than typical |
About Lagevrio (Eua): Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ It is used by adults 18 years of age and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with molnupiravir. Molnupiravir works by preventing the growth of the virus that causes COVID-19. More information about molnupiravir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use. There is limited information about how safe and effective molnupiravir is for treating COVID-19. Study results show that molnupiravir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of molnupiravir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. In 2023, this provider wrote 23 Medicare prescriptions for Lagevrio (Eua), about 1.3 times the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $10.67 per fill, versus $10.84 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 23 30-Day Fills standardized to 30-day supplies 115 Days of Medication total across all patients in 2023 | |||
| Doxycycline Hyclate | 21 | $10.83▼ below IN avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 21 Medicare prescriptions for Doxycycline Hyclate, about 72% of the volume of the typical Indiana prescriber of this medication (29). Medicare paid an average of $10.83 per fill, versus $23.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 21 30-Day Fills standardized to 30-day supplies 162 Days of Medication total across all patients in 2023 | |||
| Hydroxyzine Hcl | 20 | $5.31▼ below IN avg | ▼ Less than typical |
About Hydroxyzine Hcl: Hydroxyzine is used to treat itching caused by allergies. Show more ▾ It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery. In 2023, this provider wrote 20 Medicare prescriptions for Hydroxyzine Hcl, about 65% of the volume of the typical Indiana prescriber of this medication (31). Medicare paid an average of $5.31 per fill, versus $19.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 20 30-Day Fills standardized to 30-day supplies 155 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 18 | $10.61▼ below IN avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 18 Medicare prescriptions for Erythromycin, about half the volume of the typical Indiana prescriber of this medication (40). Medicare paid an average of $10.61 per fill, versus $26.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 18 30-Day Fills standardized to 30-day supplies 169 Days of Medication total across all patients in 2023 | |||
| Amoxicillin | 16 | $2.78▼ below IN avg | ▼ Less than typical |
About Amoxicillin: Amoxicillin is used to treat a wide variety of bacterial infections. Show more ▾ This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning. A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. In 2023, this provider wrote 16 Medicare prescriptions for Amoxicillin, about half the volume of the typical Indiana prescriber of this medication (38). Medicare paid an average of $2.78 per fill, versus $3.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 16 30-Day Fills standardized to 30-day supplies 112 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 13 | $18.76▼ below IN avg | ▼ Less than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 13 Medicare prescriptions for Acyclovir, about half the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $18.76 per fill, versus $23.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 121 Days of Medication total across all patients in 2023 | |||
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 13 | $10.58▼ below IN avg | ▼ Less than typical |
About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. In 2023, this provider wrote 13 Medicare prescriptions for Paxlovid (Eua), about half the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $10.58 per fill, versus $10.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 65 Days of Medication total across all patients in 2023 | |||
| Tobramycin | 13 | $9.17 | ▼ Less than typical |
About Tobramycin: This medication is used to treat people with a certain inherited condition (cystic fibrosis) who have an ongoing lung infection with a certain bacteria (Pseudomonas aeruginosa). Show more ▾ People with cystic fibrosis produce thick, sticky mucus that can plug up the tubes, ducts and passageways in the lungs. This can result in serious breathing problems and infections in the lungs. Tobramycin belongs to a class of drugs known as aminoglycoside antibiotics. Tobramycin inhalation solution works by stopping the growth of a certain bacteria (Pseudomonas aeruginosa) that commonly infects the lungs of people with cystic fibrosis. This effect decreases lung infections and damage, and helps to improve breathing. An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species. In 2023, this provider wrote 13 Medicare prescriptions for Tobramycin, about 17% of the volume of the typical Indiana prescriber of this medication (75). Medicare paid an average of $9.17 per fill, versus $7.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 171 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. YAMUNA KASARANENI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family Medicine prescribing approach at this Greenwood, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
